In the competitive field of Peptide Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Peptide Drugs technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Peptide Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Peptide Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Peptide Drugs industry

EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 14, 2024HOLLATZ, CHRISTIAN
EP4061399Insulinotropic And Glucagonotropic Effects Of Beta-LactoglobulinARLA FOODS AMBANov 14, 2024ZIMMERMANN & PARTNER PATENTANWALTE MBB
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 13, 2024STADA-ARZNEIMITTEL AKTIENGESELLSCHAFT
EP4061399Insulinotropic And Glucagonotropic Effects Of Beta-LactoglobulinARLA FOODS AMBANov 13, 2024N.V. NUTRICIA
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 12, 2024TEVA PHARMACEUTICAL INDUSTRIES LTD.
EP3980047Inflammatory Disease Treatment With Complement InhibitorsRA PHARMACEUTICALS, INC.Nov 11, 2024KRAUSS, JAN
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISK A/SNov 7, 2024ADALVO LTD.
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024DORRIES, HANS ULRICH
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISK A/SNov 6, 2024MAIWALD GMBH
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 6, 2024SECERNA LLP

To stay ahead in the competitive Peptide Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Peptide Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3078667Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES11
EP2949335Jan 4, 2017Low Frequency Glatiramer Acetate TherapyYEDA RESEARCH & DEVELOPMENT COMPANY, LTD.11
EP3474820Feb 7, 2024Glp-1 Compositions And Uses ThereofNOVO NORDISK A/S8
EP2350096Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS, LTD.8
EP3448416Aug 10, 2022Semaglutide In Cardiovascular ConditionsNOVO NORDISK A/S8
EP2863895Apr 14, 2021Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISK A/S7
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
EP2371361Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME GLOBAL S.À.R.L.7
EP2154244Apr 12, 2017Cell Culture Method Using Amino Acid-Enriched MediumCHUGAI SEIYAKU KABUSHIKI KAISHA7
EP3542790Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISK A/S7